Novartis articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/03/03 07:17
2015/03/03 07:17
2h
BURTON-ON-TRENT, England--(BUSINESS WIRE)--Clinigen Group plc (AIM: CLIN, Clinigen or the Group), the global specialty pharmaceuticals and pharmaceutical services business, has today published its...
2015/03/03 07:17
2015/03/03 07:17
Latest videos
2015/03/03 06:17
2015/03/03 06:17
3h
The Board of Directors of Ipsen (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, met on 2 March 2015 to review the Group’s results for 2014, published today. The annual financial report, with...
2015/03/03 06:17
2015/03/03 06:17
3h
Le Conseil d’administrationd’Ipsen (Euronext : IPN ; ADR : IPSEY), présidé par Marc de Garidel, s’est réuni le 2 mars 2015pour arrêter les comptes de l’exercice 2014 publiés aujourd’hui. Le rapport...
2015/03/02 21:18
2015/03/02 21:18
12h
WORLD FINANCE UPDATE: THE Australian dollar is hovering amid anticipation that the Reserve Bank will cut the cash rate to a new record low on Tuesday. And the Australian share market looks set to...
2015/03/02 17:04
2015/03/02 17:04
17h
LONDON (AP) - Britain's GlaxoSmithKline PLC and Switzerland's Novartis AG have completed a three-part deal that will offer the British company's shareholders a 4 billion pound ($6.17 billion)...
2015/03/02 16:51
2015/03/02 16:51
17h
There've been several big pharmaceutical takeovers in recent months. But the latest $20bln deal between Britain's GlaxoSmithKline and Switzerland's Novartis is no merger. The two drugmakers have...
2015/03/02 14:49
2015/03/02 14:49
19h
ZURICH--In January, René Scheu gathered the 19 people he employs in northeast Switzerland to discuss a serious question: How could his tiny plastics company cut enough costs to survive the sudden...
2015/03/02 10:28
2015/03/02 10:28
23h
Drug makers Novartis and GlaxoSmithKline (GSK) have announced that they have completed several transactions totalling $20bn that will transform both companies. British giant GSK is establishing a...
2015/03/02 08:13
2015/03/02 08:13
1d
Occupancy rates are at their highest in 20 years and research from PwC shows that an additional 6,430 net new rooms could open in the capital this year. Manufacturing and mortgage lending in the...
2015/03/02 00:39
2015/03/02 00:39
1d
Negative bond yields sprouting up across Europe may seem bizarre. But the strong demand for such assets shows that investors are willing to pay for flexibility, liquidity and security in “a pretty...
2015/02/28 19:01
2015/02/28 19:01
2d
Family caregivers of people with dementia are often called the invisible second clients for good reason. As many Kelowna families have found, their roles as informal caregivers are critical to the...
Paul Lee
MENTIONED
2015/02/28 09:14
2015/02/28 09:14
3d
ATLANTA (AP) - A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college...
2015/02/28 01:56
2015/02/28 01:56
3d
A month ago, we wrote about a bizarre situation involving Denmark's now totally broken monetary system, where as a result of an unprecedented scramble to weaken the currency in order to preserve the...
2015/02/27 22:38
2015/02/27 22:38
3d
Japanese health authorities said Friday that they have ordered the local unit of Swiss pharmaceutical giant Novartis to temporarily suspend its operations for failing to report drug side effects. The...
2015/02/27 21:12
2015/02/27 21:12
3d
The future of work, according to Google, will take place in woodland glades and wildflower meadows, next to trickling streams and verdant allotments, among bike paths and yoga classes and gushing...
2015/02/27 17:56
2015/02/27 17:56
3d
ZURICH: Swiss drugmaker Novartis said on Friday (Feb 27) its treatment for a leading cause of age-related blindness had met its primary goals in a study and could potentially pave the way for less...
2015/02/27 13:09
2015/02/27 13:09
3d
Salix--as well as the overall gastrointestinal market--carries some of the attributes Valeant has historically been attracted to, such as an undertreated market, minimal generic competition, and low...
2015/02/27 12:56
2015/02/27 12:56
3d
LONDON: European health regulators said on Friday they had recommended approval of a drug for advanced lung cancer developed by Swiss drugmaker Novartis that is intended to treat patients with a...
2015/02/27 11:22
2015/02/27 11:22
3d
Biotech Stock Mailbag: Receptos, Celldex Therapeutics, Exact Sciences Receptos' ozanimod is superior to Novartis'(NVS) Gilenya. That's a sweet spot for Receptos since Gilenya is a $2.6 billion-a-year...
2015/02/26 21:20
2015/02/26 21:20
4d
Cancer Drug Once Bought for $7 Million May Now Fetch $18 Billion (Bloomberg) — An overlooked drug bought by a biotech company for a mere $6.6 million a decade ago could become one of the biggest...
2015/03/03 07:17
2015/03/03 07:17
Latest from Twitter